These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Nadroparin plus aspirin versus aspirin alone in the treatment of acute ischemic stroke. Sarma GR; Roy AK Neurol India; 2003 Jun; 51(2):208-10. PubMed ID: 14571005 [TBL] [Abstract][Full Text] [Related]
28. [Anticoagulant therapy with antivitamins K]. Bokarev IN; Kabaeva EV Klin Med (Mosk); 1984 Jan; 62(1):18-24. PubMed ID: 6708415 [No Abstract] [Full Text] [Related]
29. [Complex intensive therapy of terminal disseminated intravascular coagulation and thromboembolic syndrome in Marchiafava-Micheli anemia]. Barkagan ZS; Tsiguleva OA; Abelovich IS Gematol Transfuziol; 1987 Sep; 32(9):42-4. PubMed ID: 3692126 [No Abstract] [Full Text] [Related]
30. [A choice of an anticoagulant with respect to a stage of DIC syndrome]. Zabolotskikh IB; Sin'kov SV; Shaposhnikov SA Anesteziol Reanimatol; 2004; (3):29-31. PubMed ID: 15314854 [No Abstract] [Full Text] [Related]
31. Plasma and plasma components in the management of disseminated intravascular coagulation. Levi M; de Jonge E; van der Poll T Best Pract Res Clin Haematol; 2006; 19(1):127-42. PubMed ID: 16377546 [TBL] [Abstract][Full Text] [Related]
32. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. Iba T; Levy JH; Warkentin TE; Thachil J; van der Poll T; Levi M; J Thromb Haemost; 2019 Nov; 17(11):1989-1994. PubMed ID: 31410983 [No Abstract] [Full Text] [Related]
33. Current understanding of disseminated intravascular coagulation. Levi M Br J Haematol; 2004 Mar; 124(5):567-76. PubMed ID: 14871243 [No Abstract] [Full Text] [Related]
34. [Blood anticoagulation system in the hypercoagulation syndrome in patients with pulmonary tuberculosis]. Kaminskaia GO; Martynova EV; Serebrianaia BA; Komissarova OG Probl Tuberk Bolezn Legk; 2008; (11):35-9. PubMed ID: 19140378 [TBL] [Abstract][Full Text] [Related]
35. [Correction of several parameters of homeostasis in patients with ischemic heart disease by different methods of extracorporeal treatment of blood]. Shapovalova NV; Shevtsova OM; Grekova TI Anesteziol Reanimatol; 1999; (1):29-32. PubMed ID: 10199042 [TBL] [Abstract][Full Text] [Related]
36. [Clinical significance of coagulative and fibrinolytic changes in patients with ovarian cancer and anticoagulant therapy]. Chen JT Nihon Gan Chiryo Gakkai Shi; 1983 Oct; 18(7):1863-72. PubMed ID: 6672138 [No Abstract] [Full Text] [Related]
37. [Possibilities of intensive therapy of systemic inflammatory response syndrome during purulent and septic complications in obstetrics and gynecology]. Kolesnichenko AP; Gritsan AI; Gritsan GV; Skorobogatov AIu Anesteziol Reanimatol; 2003; (2):34-7. PubMed ID: 12939940 [No Abstract] [Full Text] [Related]
38. The pathogenesis and management of disseminated intravascular coagulation. Saba HI; Morelli GA Clin Adv Hematol Oncol; 2006 Dec; 4(12):919-26. PubMed ID: 17235277 [TBL] [Abstract][Full Text] [Related]
39. Implications of anticoagulant therapy. Ellison N; Jobes DR; Schwartz AJ Int Anesthesiol Clin; 1982; 20(4):121-35. PubMed ID: 6757142 [No Abstract] [Full Text] [Related]